Covid Coronavirus Vaccine India news: The first dose of Covaxin was given to a 30-year-old man in Delhi AIIMS. Two hours later, he was discharged from the hospital.
- Covaxin trial started in Delhi AIIMS
- Dose given to only one person on the first day
- No reaction, leave after two hours
- More than 12 volunteers have received medical fitness so far
Chief Correspondent, New Delhi
Corona vaccine has begun trials at AIIMS (Covaxin). A 30-year-old man was vaccinated on the first day of the trial. The special thing is that the person did not have any kind of reaction after the vaccination and after two hours he was discharged from the hospital. Dr. Sanjay Rai, Principal Investigator of Trial at AIIMS, said that the trial has started, now gradually the number of volunteers in the trial will be increased.
According to the information that did not come after giving the vaccine , so far more than 12 volunteers have received medical fitness. Two of them were called on Friday. But one volunteer could not reach for personal reasons, so only one vaccine was given on Friday. Dr. Sanjay Rai said that the first phase of the trial is very important in terms of safety, so we kept the patient under observation for the next two hours after the vaccine. When there was no problem of any kind, he was discharged from the hospital.
Every problem the
doctor has to write in the diary told that volunteers have been given a diary, which they have to maintain. If they have any problem then write about it. He said that Volunteer will be called again for follow-up after seven days, but in the meantime if he has any kind of problem, he can come anytime. Not only this, the people of the vaccine team will be in touch with them through the phone and daily movements will be done. The vaccination program will continue on Saturday. Today three to four people can be vaccinated.
After the first phase vaccination will be completed in 15 to 20 days, its safety report will be sent to the Ethics Committee. After the review of the committee, this trial will be carried forward. A total of 100 volunteers are to be included in Phase One trial of this vaccine and this is a vaccination of two doses. In this case, the first phase may take about 15 to 20 days to complete. Please tell here that 3500 people have registered so far to participate in this ongoing trial in AIIMS.